AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 2 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,462 | +13.9% | 164 | +17.1% | 0.00% | 0.0% |
Q2 2023 | $10,061 | +20.8% | 140 | +3.7% | 0.00% | 0.0% |
Q1 2023 | $8,327 | -20.0% | 135 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $10,413 | +73.6% | 135 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $6,000 | +20.0% | 135 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $5,000 | +66.7% | 135 | +107.7% | 0.00% | – |
Q1 2022 | $3,000 | -62.5% | 65 | -68.6% | 0.00% | -100.0% |
Q4 2021 | $8,000 | +14.3% | 207 | +3.5% | 0.00% | 0.0% |
Q3 2021 | $7,000 | 0.0% | 200 | +85.2% | 0.00% | 0.0% |
Q2 2021 | $7,000 | +16.7% | 108 | -2.7% | 0.00% | 0.0% |
Q1 2021 | $6,000 | -25.0% | 111 | +11.0% | 0.00% | 0.0% |
Q4 2020 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $7,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |